EC deepens probe into Illumina’s $8bn bid for GRAIL
The EC said that the proposed acquisition may reduce competition for the cancer detection tests based on sequencing…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
23 Jul 21
The EC said that the proposed acquisition may reduce competition for the cancer detection tests based on sequencing…
16 Jul 21
The combined entity will operate as HeartFlow Group with an estimated $400m in cash
14 Jul 21
Acquisition enriches WCG's scientific and regulatory capabilities with comprehensive services ensuring quality and validity of clinical trial results
12 Jul 21
The acquisition of Vectura will allow Philip Morris to access differentiated technology and pharmaceutical development expertise to offer…
09 Jul 21
Igenomix has a global network of 26 laboratories, serving over 80 countries and more than 3000 clinics
08 Jul 21
The transaction will enable McKesson to streamline its business and investments in the areas where it has deep…
25 Jun 21
The company currently holds an equity interest of up to 27% in Farapulse
23 Jun 21
The deal is expected to provide $400 million in gross proceeds for commercialisation of Pear’s three FDA-authorised products
18 Jun 21
Mobidiag’s Amplidiag and Novodiag testing platforms hold the potential to offer results in 50 minutes to two hours
17 Jun 21
BBI Solutions offers a range of products, including antibodies, antigens, labels, complementary reagents and point of care tests